Ashima Limited
Ashima Limited (ASHIMASYN.NS) Stock Competitors & Peer Comparison
See (ASHIMASYN.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ASHIMASYN.NS | ₹16.49 | +4.10% | 3.1B | -102.50 | -₹0.16 | N/A |
| PAGEIND.BO | ₹38,114.00 | -1.12% | 427.5B | 55.86 | ₹686.14 | +1.57% |
| PAGEIND.NS | ₹38,145.00 | -1.04% | 427.2B | 55.83 | ₹686.10 | +1.57% |
| KPRMILL.NS | ₹937.55 | -1.36% | 323.4B | 37.36 | ₹25.33 | +0.53% |
| KPRMILL.BO | ₹934.20 | -1.64% | 323B | 37.30 | ₹25.33 | +0.53% |
| VTL.NS | ₹595.50 | -0.98% | 173.2B | 22.85 | ₹26.20 | +0.84% |
| VTL.BO | ₹595.55 | -1.01% | 172.7B | 22.83 | ₹26.16 | +0.84% |
| ALOKTEXT.BO | ₹37.04 | +3.81% | 161.2B | -0.72 | -₹51.22 | N/A |
| WELSPUNIND.NS | ₹159.00 | +0.03% | 153B | 29.39 | ₹5.41 | N/A |
| WELSPUNLIV.NS | ₹139.45 | +0.60% | 132.7B | 65.17 | ₹2.13 | +1.22% |
Stock Comparison
ASHIMASYN.NS vs PAGEIND.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, PAGEIND.BO has a market cap of 427.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while PAGEIND.BO trades at ₹38,114.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas PAGEIND.BO's P/E ratio is 55.86. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to PAGEIND.BO's ROE of +0.53%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PAGEIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PAGEIND.BO's competition here
ASHIMASYN.NS vs PAGEIND.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, PAGEIND.NS has a market cap of 427.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while PAGEIND.NS trades at ₹38,145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas PAGEIND.NS's P/E ratio is 55.83. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to PAGEIND.NS's ROE of +0.53%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PAGEIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PAGEIND.NS's competition here
ASHIMASYN.NS vs KPRMILL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, KPRMILL.NS has a market cap of 323.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while KPRMILL.NS trades at ₹937.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas KPRMILL.NS's P/E ratio is 37.36. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to KPRMILL.NS's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KPRMILL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KPRMILL.NS's competition here
ASHIMASYN.NS vs KPRMILL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, KPRMILL.BO has a market cap of 323B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while KPRMILL.BO trades at ₹934.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas KPRMILL.BO's P/E ratio is 37.30. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to KPRMILL.BO's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KPRMILL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KPRMILL.BO's competition here
ASHIMASYN.NS vs VTL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, VTL.NS has a market cap of 173.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while VTL.NS trades at ₹595.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas VTL.NS's P/E ratio is 22.85. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to VTL.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to VTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VTL.NS's competition here
ASHIMASYN.NS vs VTL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, VTL.BO has a market cap of 172.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while VTL.BO trades at ₹595.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas VTL.BO's P/E ratio is 22.83. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to VTL.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to VTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VTL.BO's competition here
ASHIMASYN.NS vs ALOKTEXT.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ALOKTEXT.BO has a market cap of 161.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ALOKTEXT.BO trades at ₹37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ALOKTEXT.BO's P/E ratio is -0.72. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ALOKTEXT.BO's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ALOKTEXT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ALOKTEXT.BO's competition here
ASHIMASYN.NS vs WELSPUNIND.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, WELSPUNIND.NS has a market cap of 153B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while WELSPUNIND.NS trades at ₹159.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas WELSPUNIND.NS's P/E ratio is 29.39. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to WELSPUNIND.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to WELSPUNIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check WELSPUNIND.NS's competition here
ASHIMASYN.NS vs WELSPUNLIV.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, WELSPUNLIV.NS has a market cap of 132.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while WELSPUNLIV.NS trades at ₹139.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas WELSPUNLIV.NS's P/E ratio is 65.17. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to WELSPUNLIV.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to WELSPUNLIV.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check WELSPUNLIV.NS's competition here
ASHIMASYN.NS vs WELSPUNLIV.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, WELSPUNLIV.BO has a market cap of 132.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while WELSPUNLIV.BO trades at ₹139.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas WELSPUNLIV.BO's P/E ratio is 64.81. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to WELSPUNLIV.BO's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to WELSPUNLIV.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check WELSPUNLIV.BO's competition here
ASHIMASYN.NS vs ARVIND.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ARVIND.NS has a market cap of 128.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ARVIND.NS trades at ₹484.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ARVIND.NS's P/E ratio is 31.19. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ARVIND.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ARVIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ARVIND.NS's competition here
ASHIMASYN.NS vs ARVIND.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ARVIND.BO has a market cap of 128.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ARVIND.BO trades at ₹485.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ARVIND.BO's P/E ratio is 31.84. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ARVIND.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ARVIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ARVIND.BO's competition here
ASHIMASYN.NS vs TRIDENT.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, TRIDENT.NS has a market cap of 124.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while TRIDENT.NS trades at ₹24.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas TRIDENT.NS's P/E ratio is 33.04. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to TRIDENT.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to TRIDENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TRIDENT.NS's competition here
ASHIMASYN.NS vs TRIDENT.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, TRIDENT.BO has a market cap of 124.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while TRIDENT.BO trades at ₹24.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas TRIDENT.BO's P/E ratio is 33.03. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to TRIDENT.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to TRIDENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TRIDENT.BO's competition here
ASHIMASYN.NS vs SWANENERGY.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SWANENERGY.NS has a market cap of 103.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SWANENERGY.NS trades at ₹331.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SWANENERGY.NS's P/E ratio is 13.68. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SWANENERGY.NS's ROE of -0.00%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SWANENERGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SWANENERGY.NS's competition here
ASHIMASYN.NS vs SWANENERGY.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SWANENERGY.BO has a market cap of 99.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SWANENERGY.BO trades at ₹321.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SWANENERGY.BO's P/E ratio is 12.75. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SWANENERGY.BO's ROE of -0.00%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SWANENERGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SWANENERGY.BO's competition here
ASHIMASYN.NS vs ABFRL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ABFRL.BO has a market cap of 79.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ABFRL.BO trades at ₹64.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ABFRL.BO's P/E ratio is -10.19. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ABFRL.BO's ROE of -0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ABFRL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ABFRL.BO's competition here
ASHIMASYN.NS vs ABFRL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ABFRL.NS has a market cap of 78.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ABFRL.NS trades at ₹64.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ABFRL.NS's P/E ratio is -10.17. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ABFRL.NS's ROE of -0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ABFRL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ABFRL.NS's competition here
ASHIMASYN.NS vs PGIL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, PGIL.BO has a market cap of 75.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while PGIL.BO trades at ₹1,620.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas PGIL.BO's P/E ratio is 27.24. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to PGIL.BO's ROE of +0.22%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PGIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PGIL.BO's competition here
ASHIMASYN.NS vs PGIL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, PGIL.NS has a market cap of 75.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while PGIL.NS trades at ₹1,622.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas PGIL.NS's P/E ratio is 27.25. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to PGIL.NS's ROE of +0.22%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PGIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PGIL.NS's competition here
ASHIMASYN.NS vs GARFIBRES.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GARFIBRES.NS has a market cap of 63.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GARFIBRES.NS trades at ₹649.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GARFIBRES.NS's P/E ratio is 32.05. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GARFIBRES.NS's ROE of +0.15%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GARFIBRES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GARFIBRES.NS's competition here
ASHIMASYN.NS vs GARFIBRES.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GARFIBRES.BO has a market cap of 63.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GARFIBRES.BO trades at ₹650.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GARFIBRES.BO's P/E ratio is 32.02. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GARFIBRES.BO's ROE of +0.15%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GARFIBRES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GARFIBRES.BO's competition here
ASHIMASYN.NS vs ARVINDFASN.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ARVINDFASN.BO has a market cap of 63.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ARVINDFASN.BO trades at ₹467.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ARVINDFASN.BO's P/E ratio is 51.43. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ARVINDFASN.BO's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ARVINDFASN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ARVINDFASN.BO's competition here
ASHIMASYN.NS vs ARVINDFASN.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ARVINDFASN.NS has a market cap of 63.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ARVINDFASN.NS trades at ₹468.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ARVINDFASN.NS's P/E ratio is 51.36. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ARVINDFASN.NS's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ARVINDFASN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ARVINDFASN.NS's competition here
ASHIMASYN.NS vs ALOKINDS.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ALOKINDS.NS has a market cap of 62.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ALOKINDS.NS trades at ₹12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ALOKINDS.NS's P/E ratio is -8.45. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ALOKINDS.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ALOKINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ALOKINDS.NS's competition here
ASHIMASYN.NS vs ICIL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ICIL.BO has a market cap of 61.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ICIL.BO trades at ₹312.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ICIL.BO's P/E ratio is 37.02. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ICIL.BO's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ICIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ICIL.BO's competition here
ASHIMASYN.NS vs ICIL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, ICIL.NS has a market cap of 61.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while ICIL.NS trades at ₹311.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas ICIL.NS's P/E ratio is 51.37. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to ICIL.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ICIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ICIL.NS's competition here
ASHIMASYN.NS vs GOKEX.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GOKEX.BO has a market cap of 51.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GOKEX.BO trades at ₹694.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GOKEX.BO's P/E ratio is 45.12. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GOKEX.BO's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GOKEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GOKEX.BO's competition here
ASHIMASYN.NS vs GOKEX.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GOKEX.NS has a market cap of 51.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GOKEX.NS trades at ₹693.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GOKEX.NS's P/E ratio is 53.69. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GOKEX.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GOKEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GOKEX.NS's competition here
ASHIMASYN.NS vs GBGLOBAL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GBGLOBAL.NS has a market cap of 46.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GBGLOBAL.NS trades at ₹930.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GBGLOBAL.NS's P/E ratio is -0.03. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GBGLOBAL.NS's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GBGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GBGLOBAL.NS's competition here
ASHIMASYN.NS vs RAYMONDLSL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RAYMONDLSL.BO has a market cap of 44B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RAYMONDLSL.BO trades at ₹710.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RAYMONDLSL.BO's P/E ratio is 92.71. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RAYMONDLSL.BO's ROE of +0.00%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RAYMONDLSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAYMONDLSL.BO's competition here
ASHIMASYN.NS vs RAYMONDLSL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RAYMONDLSL.NS has a market cap of 44B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RAYMONDLSL.NS trades at ₹710.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RAYMONDLSL.NS's P/E ratio is 92.55. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RAYMONDLSL.NS's ROE of +0.00%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RAYMONDLSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAYMONDLSL.NS's competition here
ASHIMASYN.NS vs LUXIND.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, LUXIND.BO has a market cap of 41.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while LUXIND.BO trades at ₹1,433.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas LUXIND.BO's P/E ratio is 38.67. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to LUXIND.BO's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to LUXIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check LUXIND.BO's competition here
ASHIMASYN.NS vs LUXIND.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, LUXIND.NS has a market cap of 41.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while LUXIND.NS trades at ₹1,438.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas LUXIND.NS's P/E ratio is 38.73. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to LUXIND.NS's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to LUXIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check LUXIND.NS's competition here
ASHIMASYN.NS vs TCNSBRANDS.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, TCNSBRANDS.BO has a market cap of 37B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while TCNSBRANDS.BO trades at ₹584.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas TCNSBRANDS.BO's P/E ratio is -11.87. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to TCNSBRANDS.BO's ROE of -0.63%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to TCNSBRANDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TCNSBRANDS.BO's competition here
ASHIMASYN.NS vs TCNSBRANDS.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, TCNSBRANDS.NS has a market cap of 36.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while TCNSBRANDS.NS trades at ₹583.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas TCNSBRANDS.NS's P/E ratio is -11.85. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to TCNSBRANDS.NS's ROE of -0.63%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to TCNSBRANDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TCNSBRANDS.NS's competition here
ASHIMASYN.NS vs RAYMOND.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RAYMOND.BO has a market cap of 36.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RAYMOND.BO trades at ₹532.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RAYMOND.BO's P/E ratio is 70.27. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RAYMOND.BO's ROE of +1.53%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to RAYMOND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAYMOND.BO's competition here
ASHIMASYN.NS vs RAYMOND.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RAYMOND.NS has a market cap of 36.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RAYMOND.NS trades at ₹532.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RAYMOND.NS's P/E ratio is 108.42. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RAYMOND.NS's ROE of +1.53%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to RAYMOND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAYMOND.NS's competition here
ASHIMASYN.NS vs KITEX.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, KITEX.BO has a market cap of 32.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while KITEX.BO trades at ₹161.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas KITEX.BO's P/E ratio is -19.33. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to KITEX.BO's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KITEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KITEX.BO's competition here
ASHIMASYN.NS vs KITEX.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, KITEX.NS has a market cap of 32.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while KITEX.NS trades at ₹161.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas KITEX.NS's P/E ratio is -19.32. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to KITEX.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KITEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KITEX.NS's competition here
ASHIMASYN.NS vs MAYURUNIQ.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, MAYURUNIQ.NS has a market cap of 32.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while MAYURUNIQ.NS trades at ₹777.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas MAYURUNIQ.NS's P/E ratio is 16.92. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to MAYURUNIQ.NS's ROE of +0.19%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to MAYURUNIQ.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MAYURUNIQ.NS's competition here
ASHIMASYN.NS vs MAYURUNIQ.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, MAYURUNIQ.BO has a market cap of 32.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while MAYURUNIQ.BO trades at ₹778.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas MAYURUNIQ.BO's P/E ratio is 16.92. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to MAYURUNIQ.BO's ROE of +0.19%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to MAYURUNIQ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MAYURUNIQ.BO's competition here
ASHIMASYN.NS vs JINDWORLD.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, JINDWORLD.NS has a market cap of 30.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while JINDWORLD.NS trades at ₹30.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas JINDWORLD.NS's P/E ratio is 45.68. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to JINDWORLD.NS's ROE of +0.09%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to JINDWORLD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check JINDWORLD.NS's competition here
ASHIMASYN.NS vs JINDWORLD.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, JINDWORLD.BO has a market cap of 30.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while JINDWORLD.BO trades at ₹30.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas JINDWORLD.BO's P/E ratio is 45.65. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to JINDWORLD.BO's ROE of +0.09%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to JINDWORLD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check JINDWORLD.BO's competition here
ASHIMASYN.NS vs NITINSPIN.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, NITINSPIN.NS has a market cap of 28B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while NITINSPIN.NS trades at ₹494.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas NITINSPIN.NS's P/E ratio is 15.78. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to NITINSPIN.NS's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NITINSPIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NITINSPIN.NS's competition here
ASHIMASYN.NS vs NITINSPIN.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, NITINSPIN.BO has a market cap of 28B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while NITINSPIN.BO trades at ₹494.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas NITINSPIN.BO's P/E ratio is 16.79. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to NITINSPIN.BO's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NITINSPIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NITINSPIN.BO's competition here
ASHIMASYN.NS vs KKCL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, KKCL.BO has a market cap of 27.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while KKCL.BO trades at ₹434.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas KKCL.BO's P/E ratio is 19.18. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to KKCL.BO's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KKCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KKCL.BO's competition here
ASHIMASYN.NS vs KKCL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, KKCL.NS has a market cap of 27.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while KKCL.NS trades at ₹438.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas KKCL.NS's P/E ratio is 19.14. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to KKCL.NS's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KKCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KKCL.NS's competition here
ASHIMASYN.NS vs SIYSIL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SIYSIL.BO has a market cap of 26.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SIYSIL.BO trades at ₹583.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SIYSIL.BO's P/E ratio is 11.62. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SIYSIL.BO's ROE of +0.17%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SIYSIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SIYSIL.BO's competition here
ASHIMASYN.NS vs SIYSIL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SIYSIL.NS has a market cap of 26.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SIYSIL.NS trades at ₹579.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SIYSIL.NS's P/E ratio is 11.61. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SIYSIL.NS's ROE of +0.17%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SIYSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SIYSIL.NS's competition here
ASHIMASYN.NS vs SANGAMIND.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SANGAMIND.BO has a market cap of 26.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SANGAMIND.BO trades at ₹515.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SANGAMIND.BO's P/E ratio is 31.58. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SANGAMIND.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SANGAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SANGAMIND.BO's competition here
ASHIMASYN.NS vs BOMDYEING.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, BOMDYEING.NS has a market cap of 26B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while BOMDYEING.NS trades at ₹128.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas BOMDYEING.NS's P/E ratio is 96.88. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to BOMDYEING.NS's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to BOMDYEING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check BOMDYEING.NS's competition here
ASHIMASYN.NS vs BOMDYEING.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, BOMDYEING.BO has a market cap of 26B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while BOMDYEING.BO trades at ₹128.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas BOMDYEING.BO's P/E ratio is 26.72. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to BOMDYEING.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to BOMDYEING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check BOMDYEING.BO's competition here
ASHIMASYN.NS vs SANGAMIND.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SANGAMIND.NS has a market cap of 25.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SANGAMIND.NS trades at ₹515.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SANGAMIND.NS's P/E ratio is 31.59. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SANGAMIND.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SANGAMIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SANGAMIND.NS's competition here
ASHIMASYN.NS vs GANECOS.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GANECOS.BO has a market cap of 25.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GANECOS.BO trades at ₹966.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GANECOS.BO's P/E ratio is 64.10. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GANECOS.BO's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GANECOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GANECOS.BO's competition here
ASHIMASYN.NS vs GANECOS.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GANECOS.NS has a market cap of 25.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GANECOS.NS trades at ₹967.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GANECOS.NS's P/E ratio is 64.20. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GANECOS.NS's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GANECOS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GANECOS.NS's competition here
ASHIMASYN.NS vs SPORTKING.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SPORTKING.BO has a market cap of 22.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SPORTKING.BO trades at ₹179.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SPORTKING.BO's P/E ratio is 19.07. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SPORTKING.BO's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SPORTKING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPORTKING.BO's competition here
ASHIMASYN.NS vs SPORTKING.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SPORTKING.NS has a market cap of 22.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SPORTKING.NS trades at ₹179.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SPORTKING.NS's P/E ratio is 19.04. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SPORTKING.NS's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SPORTKING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPORTKING.NS's competition here
ASHIMASYN.NS vs FILATEX.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, FILATEX.NS has a market cap of 19.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while FILATEX.NS trades at ₹46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas FILATEX.NS's P/E ratio is 10.60. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to FILATEX.NS's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to FILATEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check FILATEX.NS's competition here
ASHIMASYN.NS vs FILATEX.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, FILATEX.BO has a market cap of 19.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while FILATEX.BO trades at ₹46.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas FILATEX.BO's P/E ratio is 10.24. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to FILATEX.BO's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to FILATEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check FILATEX.BO's competition here
ASHIMASYN.NS vs SPAL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SPAL.BO has a market cap of 18.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SPAL.BO trades at ₹751.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SPAL.BO's P/E ratio is 16.76. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SPAL.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPAL.BO's competition here
ASHIMASYN.NS vs SPAL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SPAL.NS has a market cap of 18.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SPAL.NS trades at ₹750.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SPAL.NS's P/E ratio is 16.74. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SPAL.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SPAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPAL.NS's competition here
ASHIMASYN.NS vs CANTABIL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, CANTABIL.BO has a market cap of 18.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while CANTABIL.BO trades at ₹219.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas CANTABIL.BO's P/E ratio is 20.70. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to CANTABIL.BO's ROE of +0.23%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CANTABIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CANTABIL.BO's competition here
ASHIMASYN.NS vs CANTABIL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, CANTABIL.NS has a market cap of 18.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while CANTABIL.NS trades at ₹218.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas CANTABIL.NS's P/E ratio is 20.59. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to CANTABIL.NS's ROE of +0.23%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CANTABIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CANTABIL.NS's competition here
ASHIMASYN.NS vs SUMEETINDS.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SUMEETINDS.NS has a market cap of 15.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SUMEETINDS.NS trades at ₹28.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SUMEETINDS.NS's P/E ratio is 0.60. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SUMEETINDS.NS's ROE of +0.90%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SUMEETINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SUMEETINDS.NS's competition here
ASHIMASYN.NS vs DOLLAR.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, DOLLAR.NS has a market cap of 15B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while DOLLAR.NS trades at ₹268.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas DOLLAR.NS's P/E ratio is 14.37. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to DOLLAR.NS's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to DOLLAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DOLLAR.NS's competition here
ASHIMASYN.NS vs DOLLAR.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, DOLLAR.BO has a market cap of 15B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while DOLLAR.BO trades at ₹268.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas DOLLAR.BO's P/E ratio is 14.36. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to DOLLAR.BO's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to DOLLAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DOLLAR.BO's competition here
ASHIMASYN.NS vs AYMSYNTEX.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, AYMSYNTEX.NS has a market cap of 12.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while AYMSYNTEX.NS trades at ₹219.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas AYMSYNTEX.NS's P/E ratio is -836.38. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to AYMSYNTEX.NS's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to AYMSYNTEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AYMSYNTEX.NS's competition here
ASHIMASYN.NS vs AYMSYNTEX.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, AYMSYNTEX.BO has a market cap of 12.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while AYMSYNTEX.BO trades at ₹222.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas AYMSYNTEX.BO's P/E ratio is -804.44. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to AYMSYNTEX.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to AYMSYNTEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AYMSYNTEX.BO's competition here
ASHIMASYN.NS vs FAZE3Q.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, FAZE3Q.BO has a market cap of 12.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while FAZE3Q.BO trades at ₹525.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas FAZE3Q.BO's P/E ratio is 39.42. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to FAZE3Q.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to FAZE3Q.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check FAZE3Q.BO's competition here
ASHIMASYN.NS vs FAZE3Q.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, FAZE3Q.NS has a market cap of 12.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while FAZE3Q.NS trades at ₹523.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas FAZE3Q.NS's P/E ratio is 39.38. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to FAZE3Q.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to FAZE3Q.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check FAZE3Q.NS's competition here
ASHIMASYN.NS vs RUPA.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RUPA.BO has a market cap of 12B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RUPA.BO trades at ₹155.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RUPA.BO's P/E ratio is 18.01. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RUPA.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RUPA.BO's competition here
ASHIMASYN.NS vs RUPA.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RUPA.NS has a market cap of 12B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RUPA.NS trades at ₹155.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RUPA.NS's P/E ratio is 17.98. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RUPA.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to RUPA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RUPA.NS's competition here
ASHIMASYN.NS vs INDORAMA.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, INDORAMA.BO has a market cap of 11.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while INDORAMA.BO trades at ₹42.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas INDORAMA.BO's P/E ratio is 8.55. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to INDORAMA.BO's ROE of +0.37%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to INDORAMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check INDORAMA.BO's competition here
ASHIMASYN.NS vs INDORAMA.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, INDORAMA.NS has a market cap of 11.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while INDORAMA.NS trades at ₹41.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas INDORAMA.NS's P/E ratio is 8.47. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to INDORAMA.NS's ROE of +0.37%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to INDORAMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check INDORAMA.NS's competition here
ASHIMASYN.NS vs MONTECARLO.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, MONTECARLO.NS has a market cap of 11.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while MONTECARLO.NS trades at ₹556.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas MONTECARLO.NS's P/E ratio is 10.12. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to MONTECARLO.NS's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to MONTECARLO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MONTECARLO.NS's competition here
ASHIMASYN.NS vs RAJRILTD.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RAJRILTD.NS has a market cap of 11.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RAJRILTD.NS trades at ₹20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RAJRILTD.NS's P/E ratio is 48.26. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RAJRILTD.NS's ROE of +0.25%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RAJRILTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAJRILTD.NS's competition here
ASHIMASYN.NS vs MONTECARLO.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, MONTECARLO.BO has a market cap of 11.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while MONTECARLO.BO trades at ₹552.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas MONTECARLO.BO's P/E ratio is 10.04. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to MONTECARLO.BO's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to MONTECARLO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MONTECARLO.BO's competition here
ASHIMASYN.NS vs CENTENKA.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, CENTENKA.BO has a market cap of 10.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while CENTENKA.BO trades at ₹493.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas CENTENKA.BO's P/E ratio is 18.54. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to CENTENKA.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CENTENKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CENTENKA.BO's competition here
ASHIMASYN.NS vs CENTENKA.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, CENTENKA.NS has a market cap of 10.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while CENTENKA.NS trades at ₹492.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas CENTENKA.NS's P/E ratio is 15.85. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to CENTENKA.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CENTENKA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CENTENKA.NS's competition here
ASHIMASYN.NS vs HIMATSEIDE.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, HIMATSEIDE.BO has a market cap of 10.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while HIMATSEIDE.BO trades at ₹79.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas HIMATSEIDE.BO's P/E ratio is 11.85. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to HIMATSEIDE.BO's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to HIMATSEIDE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check HIMATSEIDE.BO's competition here
ASHIMASYN.NS vs HIMATSEIDE.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, HIMATSEIDE.NS has a market cap of 10.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while HIMATSEIDE.NS trades at ₹79.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas HIMATSEIDE.NS's P/E ratio is 12.22. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to HIMATSEIDE.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to HIMATSEIDE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check HIMATSEIDE.NS's competition here
ASHIMASYN.NS vs PRECOT.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, PRECOT.NS has a market cap of 9.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while PRECOT.NS trades at ₹844.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas PRECOT.NS's P/E ratio is 27.54. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to PRECOT.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PRECOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PRECOT.NS's competition here
ASHIMASYN.NS vs NAHARSPING.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, NAHARSPING.BO has a market cap of 9.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while NAHARSPING.BO trades at ₹270.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas NAHARSPING.BO's P/E ratio is 28.71. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to NAHARSPING.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NAHARSPING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NAHARSPING.BO's competition here
ASHIMASYN.NS vs AMBIKCO.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, AMBIKCO.NS has a market cap of 9.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while AMBIKCO.NS trades at ₹1,661.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas AMBIKCO.NS's P/E ratio is 15.18. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to AMBIKCO.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to AMBIKCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AMBIKCO.NS's competition here
ASHIMASYN.NS vs AMBIKCO.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, AMBIKCO.BO has a market cap of 9.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while AMBIKCO.BO trades at ₹1,663.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas AMBIKCO.BO's P/E ratio is 15.14. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to AMBIKCO.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to AMBIKCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AMBIKCO.BO's competition here
ASHIMASYN.NS vs NAHARSPING.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, NAHARSPING.NS has a market cap of 9.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while NAHARSPING.NS trades at ₹265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas NAHARSPING.NS's P/E ratio is 48.34. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to NAHARSPING.NS's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NAHARSPING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NAHARSPING.NS's competition here
ASHIMASYN.NS vs GHCLTEXTIL.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GHCLTEXTIL.NS has a market cap of 9.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GHCLTEXTIL.NS trades at ₹100.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GHCLTEXTIL.NS's P/E ratio is 16.06. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GHCLTEXTIL.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GHCLTEXTIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GHCLTEXTIL.NS's competition here
ASHIMASYN.NS vs GHCLTEXTIL.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, GHCLTEXTIL.BO has a market cap of 9.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while GHCLTEXTIL.BO trades at ₹100.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas GHCLTEXTIL.BO's P/E ratio is 16.02. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to GHCLTEXTIL.BO's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GHCLTEXTIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GHCLTEXTIL.BO's competition here
ASHIMASYN.NS vs RUBYMILLS.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RUBYMILLS.BO has a market cap of 8.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RUBYMILLS.BO trades at ₹251.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RUBYMILLS.BO's P/E ratio is 16.02. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RUBYMILLS.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RUBYMILLS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RUBYMILLS.BO's competition here
ASHIMASYN.NS vs RUBYMILLS.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RUBYMILLS.NS has a market cap of 8.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RUBYMILLS.NS trades at ₹251.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RUBYMILLS.NS's P/E ratio is 17.51. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RUBYMILLS.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RUBYMILLS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RUBYMILLS.NS's competition here
ASHIMASYN.NS vs RSWM.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RSWM.NS has a market cap of 8.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RSWM.NS trades at ₹181.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RSWM.NS's P/E ratio is 16.21. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RSWM.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RSWM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RSWM.NS's competition here
ASHIMASYN.NS vs RSWM.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, RSWM.BO has a market cap of 8.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while RSWM.BO trades at ₹181.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas RSWM.BO's P/E ratio is 105.03. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to RSWM.BO's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RSWM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RSWM.BO's competition here
ASHIMASYN.NS vs SARLAPOLY.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SARLAPOLY.BO has a market cap of 8.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SARLAPOLY.BO trades at ₹98.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SARLAPOLY.BO's P/E ratio is 12.07. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SARLAPOLY.BO's ROE of -0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SARLAPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SARLAPOLY.BO's competition here
ASHIMASYN.NS vs SARLAPOLY.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, SARLAPOLY.NS has a market cap of 8.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while SARLAPOLY.NS trades at ₹98.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas SARLAPOLY.NS's P/E ratio is -62.45. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to SARLAPOLY.NS's ROE of -0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SARLAPOLY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SARLAPOLY.NS's competition here
ASHIMASYN.NS vs UNITEDPOLY.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, UNITEDPOLY.NS has a market cap of 7.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while UNITEDPOLY.NS trades at ₹34.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas UNITEDPOLY.NS's P/E ratio is -7.63. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to UNITEDPOLY.NS's ROE of +0.23%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to UNITEDPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check UNITEDPOLY.NS's competition here
ASHIMASYN.NS vs CHEVIOT.BO Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, CHEVIOT.BO has a market cap of 6.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while CHEVIOT.BO trades at ₹1,115.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas CHEVIOT.BO's P/E ratio is 9.30. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to CHEVIOT.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CHEVIOT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CHEVIOT.BO's competition here
ASHIMASYN.NS vs CHEVIOT.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, CHEVIOT.NS has a market cap of 6.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while CHEVIOT.NS trades at ₹1,095.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas CHEVIOT.NS's P/E ratio is 9.30. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to CHEVIOT.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CHEVIOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CHEVIOT.NS's competition here
ASHIMASYN.NS vs IRISDOREME.NS Comparison May 2026
ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASHIMASYN.NS stands at 3.1B. In comparison, IRISDOREME.NS has a market cap of 6.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹16.49, while IRISDOREME.NS trades at ₹36.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASHIMASYN.NS currently has a P/E ratio of -102.50, whereas IRISDOREME.NS's P/E ratio is 48.22. In terms of profitability, ASHIMASYN.NS's ROE is -0.03%, compared to IRISDOREME.NS's ROE of +0.15%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to IRISDOREME.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check IRISDOREME.NS's competition here